Aspire Biopharma Holdings, Inc. (ASBP) - Dilution Analysis

10-Q filing | 1.3M shares outstanding

8-K filing: Stock split 1-for-30 | Outstanding: 5,024,142 → 167,471

S-1/A filing: This S-1/A filing from Aspire Biopharma Holdings, Inc. outlines the company's business, growth strategy, intellectual property, recent developments including acquisitions and financing agreements, regulatory environment, and risk factors for potential investors.

10-K filing | 5.0M shares outstanding

8-K filing: The Company entered into a Purchase Agreement with Arena Business Solutions Global SPC II, Ltd., providing the Company with the right to direct Arena to purchase up to $100,000,000 in shares of the Company's common stock, and issued Transaction Fee Shares and shares to cover fees.

S-1/A filing: This S-1/A filing by Aspire Biopharma Holdings, Inc. includes information about the company's business, intellectual property, recent transactions, and risk factors, as well as information about up to 73,588,712 shares of Common Stock issuable upon the conversion of Notes.

S-1 filing: This S-1 filing outlines Aspire Biopharma Holdings, Inc.'s business, including its development of sublingual drug delivery technologies, commercialization plans for aspirin products, and various financial agreements, while also addressing risks and regulatory aspects.

10-Q filing | 49.3M shares outstanding

10-Q filing | 49.5M shares outstanding

S-1 filing: Aspire Biopharma, Inc. is filing an S-1 to register the resale of common stock held by selling shareholders, including shares issuable upon exercise of warrants, and also discusses ELOC and Securities Purchase Agreements for potential future sales of common stock and convertible debentures.

8-K filing: Aspire Biopharma Holdings, Inc. entered into a Settlement Agreement with Lenders to resolve default notices and amend loan agreements, including issuing 625,000 shares of common stock to Blackstone Capital Advisors, Inc.

S-1 filing: Aspire is an early-stage biopharmaceutical company engaged in developing and marketing disruptive technology for novel sublingual delivery mechanisms.

10-K filing | 48.9M shares outstanding

8-K filing: The company issued debentures and common stock to investors, amended a subscription agreement with Blackstone, and amended its articles of incorporation and bylaws in connection with a business combination.

8-K filing: The Company entered into an Equity Line of Credit Agreement with Arena Business Solutions Global SPC II, Ltd., allowing the Company to sell up to $100,000,000 in shares of common stock to Arena, and issued 1,893,473 shares of common stock to Arena as consideration.

8-K filing: Holders of 507,631 Class A ordinary shares elected to redeem their shares for cash at $11.43 per share, resulting in approximately $5,802,222.33 being removed from the Company's trust account. ($5.8M proceeds)

8-K filing: PowerUp Acquisition Corp. entered into a subscription agreement, a promissory note, and a registration rights agreement with Blackstone Capital Advisors, Inc. in connection with its efforts to consummate the Business Combination with Aspire Biopharma, Inc.; Blackstone may loan up to $500,000 to the Company.

10-Q filing | 7.8M shares outstanding

10-Q filing | 8.5M shares outstanding

10-Q filing | 7.8M shares outstanding

8-K filing: PowerUp Acquisition Corp. entered into a non-redemption agreement with an unaffiliated third-party shareholder, where the Sponsor will transfer shares in exchange for the shareholder agreeing not to redeem a to be determined amount of the Company's Class A ordinary shares.

8-K filing: PowerUp Acquisition Corp. is entering into non-redemption agreements with certain shareholders, where the Sponsor will transfer 50,000 Class A ordinary shares for every 150,000 Non-Redeemed Shares.

10-K filing | 9.0M shares outstanding

10-Q filing | 9.0M shares outstanding

8-K filing: New Sponsor purchased 4,317,500 Class A ordinary shares and 6,834,333 private placement warrants from the Original Sponsor for $1.00, and assumed related responsibilities and obligations. ($0.0M proceeds)

10-Q filing | 7.2M shares outstanding

8-K filing: PowerUp Acquisition Corp. entered into a purchase agreement with SRIRAMA Associates, LLC, for the sale of 4,317,500 Class A Ordinary Shares and 6,834,333 private placement warrants from PowerUp Sponsor LLC for $1.00, with the closing expected on or before August 18, 2023. ($0.0M proceeds)

8-K filing: Initial Shareholders converted 7,187,500 Class B ordinary shares into 7,187,500 Class A ordinary shares on a one-for-one basis. Following the conversion and redemptions, the Company has approximately 8,991,229 Class A ordinary shares issued and outstanding and no Class B ordinary shares issued and outstanding.

8-K filing: PowerUp Sponsor LLC entered into Non-Redemption Agreements with unaffiliated third parties, where the Sponsor will transfer 750,000 Class B ordinary shares in exchange for the third parties agreeing not to redeem 1,500,000 Class A ordinary shares.

10-Q filing | 28.8M shares outstanding

8-K filing: PowerUp Acquisition Corp. entered into Non-Redemption Agreements with unaffiliated third parties, where the Sponsor agreed to transfer an aggregate of 375,000 Class B Ordinary Shares in exchange for the third parties agreeing not to redeem an aggregate of 750,000 Class A ordinary shares.

8-K filing: PowerUp Sponsor LLC entered into a Non-Redemption Agreement with an unaffiliated third party, transferring 75,000 Class B ordinary shares in exchange for the third party agreeing not to redeem 150,000 Class A ordinary shares.

10-K filing | 7.2M shares outstanding

10-Q filing | 7.2M shares outstanding

10-Q filing | 7.2M shares outstanding

10-Q filing | 7.2M shares outstanding

8-K filing: PowerUp Acquisition Corp. consummated its initial public offering of 28,750,000 units at $10.00 per unit, generating gross proceeds of $287,500,000, and completed the private sale of 9,763,333 warrants to the Sponsor at $1.50 per warrant, generating gross proceeds of $14,645,000. ($302.15M proceeds)

8-K filing: PowerUp Acquisition Corp. consummated its initial public offering of 28,750,000 units at $10.00 per unit, generating gross proceeds of $287,500,000, and also completed the private sale of 9,763,333 warrants to the Sponsor at $1.50 per warrant, generating gross proceeds of $14,645,000. ($302.15M proceeds)

S-1/A filing: PowerUp Acquisition Corp. is offering 25,000,000 units at $10.00 per unit, each unit consisting of one Class A ordinary share and one-half of one redeemable warrant, along with a concurrent private placement of warrants to its sponsor.

S-1 filing: PowerUp Acquisition Corp. is offering 22,500,000 units at $10.00 per unit, each unit consisting of one Class A ordinary share and one-half of one redeemable warrant, in an initial public offering.